anti-Notch-1 mabs (NIH/Viragen)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameanti-Notch-1 mabs (NIH/Viragen)
Drug Alias Nameanticancer antibodies (Viragen/Biosciences)anti-Notch-1 monoclonal antibodies (NIH/Viragen)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionNeurogenic locus notch homolog protein 1 inhibitors
TargetsNeurogenic locus notch homolog protein 1
Therapy Area/IndicationsUterine Cervical NeoplasmsLung NeoplasmsBreast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesWorld
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthViragen
Active IndicationsN/A
Inactive IndicationsUterine Cervical NeoplasmsLung NeoplasmsBreast Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A